Effects of taurocholic acid on glycemic, glucagon-like peptide-1, and insulin responses to small intestinal glucose infusion in healthy humans

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages

  Wu, Tongzhi ^a   Bound, Michelle J ^a   Standfield, Scott D ^a   Jones, Karen L ^a   Horowitz, Michael ^a   Rayner, Christopher K ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; TAUROSELCHOLIC ACID;

ADULT; ARTICLE; ASPIRATION CATHETER; BALLOON CATHETER; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG ACTIVITY; DRUG ADMINISTRATION ROUTE; DRUG EFFECT; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INSULIN BLOOD LEVEL; INTRAJEJUNAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYLORUS; RANDOMIZED CONTROLLED TRIAL; SMALL INTESTINE ABSORPTION;

ADULT; BLOOD GLUCOSE; C-PEPTIDE; CHOLAGOGUES AND CHOLERETICS; DOUBLE-BLIND METHOD; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; HEALTH; HUMANS; INFUSION PUMPS; INSULIN; INTESTINE, SMALL; MALE; TAUROCHOLIC ACID;

ANIMALIA;

EID: 84876248677     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3961     Document Type: Article

References (20)

1. Koop I, Schindler M, Bosshammer A., Scheibner J, Stange E, Koop H. Physiological control of cholecystokinin release and pancreatic enzyme secretion by intraduodenal bile acids. Gut. 1996; 39:661-667.
2. Penagini R, Misiewicz JJ, Frost PG Effect of jejunal infusion of bile acids on small bowel transit and fasting jejunal motility in man. Gut. 1988; 29:789-794.
3. Nguyen A, Bouscarel B. Bile acids and signal transduction: role in glucose homeostasis. Cell Signal. 2008; 20:2180-2197.
4. Ma K, Saha PK, Chan L, Moore DD Farnesoid X receptor is essential for normal glucose homeostasis. J Clin Invest. 2006; 116: 1102-1109.
5. Reimann F, Habib AM, Tolhurst G, Parker H.E., Rogers GJ, Gribble FM Glucose sensing in L cells: a primary cell study. Cell Metab. 2008; 8:532-539.
6. Holst JJ, Vilsbøll T, Deacon CF The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol. 2009; 297:127-136.
7. Eissele R, Göke R, Willemer S., et al Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man. Eur J Clin Invest. 1992; 22:283-291.
8. Thomas C, Gioiello A, Noriega L., et al TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009; 10:167-177.
9. Rafferty EP, Wylie AR, Hand K.H., Elliott CE, Grieve DJ, Green BD Investigating the effects of physiological bile acids on GLP-1 secretion and glucose tolerance in normal and GLP-1R(-/-) mice. Biol Chem. 2011; 392:539-546.
10. Wu T, Bound MJ, Standfield S.D., Gedulin B., Jones KL, Horowitz M, Rayner CK Effects of rectal administration of taurocholic acid on glucagon-like peptide-1 and peptide YY secretion in healthy humans [published online ahead of print November 26, 2012]. Diabetes Obes Metab. doi:10.1111/dom.12043.
11. Adrian TE, Gariballa S, Parekh K.A., et al Rectal taurocholate increases L cell and insulin secretion, and decreases blood glucose and food intake in obese type 2 diabetic volunteers. Diabetologia. 2012; 55:2343-2347.
12. Little TJ, Doran S, Meyer J.H., et al. The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposed. Am J Physiol Endocrinol Metab. 2006; 291: E647-E655.
13. von Richter O., Greiner B, Fromm M.F., et al Determination of in vivo absorption, metabolism, and transport of drugs by the human intestinal wall and liver with a novel perfusion technique. Clin Pharmacol Ther. 2001; 70:217-227.
14. Chaikomin R, Wu KL, Doran S, et al Concurrent duodenal mano-metric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release. Am J Physiol Gastrointest Liver Physiol. 2007; 292:G1099-1104.
15. Brown BD, Ammon HV Effect of glucose on jejunal water and solute absorption in the presence of glycodeoxycholate and oleate in man. Dig Dis Sci. 1981; 26:710-717.
16. Brener W, Hendrix TR, McHugh PR Regulation of the gastric emptying of glucose. Gastroenterology. 1983; 85:76-82.
17. Little TJ, Feltrin KL, Horowitz M, et al Dose-related effectsoflauric acid on antropyloroduodenal motility, gastrointestinal hormone release, appetite, and energy intakeinhealthy men. Am J Physiol Regul Integr Comp Physiol. 2005; 289:R1090-R1098.
18. Sato H, Macchiarulo A, Thomas C., et al Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. J Med Chem. 2008; 51:1831-1841.
19. Qualmann C, Nauck MA, Holst J.J., Orskov C., Creutzfeldt W. Glu-cagon-like peptide 1 (7-36 amide) secretion in response to luminal sucrose from the upper and lower gut. A study using alpha-gluco-sidase inhibition (acarbose). Scand J Gastroenterol. 1995; 30:892-896.
20. Björnsson O.G., Fletcher DR, Christofides N.D., Bloom SR, Chadwick VS Duodenal perfusion with sodium taurocholate inhibits biliary but not pancreatic secretion in man. Clin Sci. 1982; 62:651-659.